Product Information
PROPAFENONE HCL 150 MG TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $0.1139 per EA under NDC 00591058201. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
150 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00591058201
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PROPAFENONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075203On Market Since
10/24/2000
Pharmacological Classes
Price Statistics
The NADAC for PROPAFENONE HCL 150 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 37.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1139 per EA |
|---|---|
| All-time high | $0.1951 (Jul 15, 2015) |
| All-time low | $0.1035 (Nov 20, 2024) |
| 52-week high | $0.1196 |
| 52-week low | $0.1081 |
| Median price | $0.1496 |
| Average price | $0.1485 |
| Largest weekly change | +31.1% (Nov 22, 2023) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Propafenone hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of PROPAFENONE HCL 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PROPAFENONE HCL 150 MG TABLET, manufactured by Actavis Pharma, Inc., is $0.1139 per EA (NDC 00591058201), effective Jun 24, 2026.
How has the price of PROPAFENONE HCL 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for PROPAFENONE HCL 150 MG TABLET has declined 37.0%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PROPAFENONE HCL 150 MG TABLET?
Since Nov 28, 2013, the NADAC for PROPAFENONE HCL 150 MG TABLET has ranged from a low of $0.1035 (Nov 20, 2024) to a high of $0.1951 (Jul 15, 2015), with a median of $0.1496 per EA.
Are there cheaper alternatives to PROPAFENONE HCL 150 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of PROPAFENONE HCL 150 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures PROPAFENONE HCL 150 MG TABLET?
PROPAFENONE HCL 150 MG TABLET (NDC 00591058201) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification